fda warning letter compounding semaglutide october 2025 WRTV Investigates has learned the sent 30 letters to telehealth companies for illegally marketing compounded GLP-1s. MORE Drugmakers battle pharmacies over compounded

Simultaneous GLP-1, GIP, and glucagon receptor activity may help clarify how endocrine pathways coordinate metabolic responses

Ozempic, Wegovy, and Rybelsus Whats the difference between compounded semaglutide and the commercially available versions

For type 2 diabetes, the FDA-approved maintenance doses of Ozempic range from 0.5 mg to 2.0 mg weekly, while the weight management indication (Wegovy) follows a specific titration schedule (0.250.51.01.72.4 mg at approximately 4-week intervals), with a maximum dose of 2.4 mg weekly

However, no peer-reviewed human clinical trials have been published to date

Chen YJ, Finkbeiner SR, Weinblatt D, Emmett MJ, Tameire F, Yousefi M, et al